These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 33165736)
1. A Role of the Podoplanin-CLEC-2 Axis in Promoting Inflammatory Response After Ischemic Stroke in Mice. Meng D; Ma X; Li H; Wu X; Cao Y; Miao Z; Zhang X Neurotox Res; 2021 Apr; 39(2):477-488. PubMed ID: 33165736 [TBL] [Abstract][Full Text] [Related]
2. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Suzuki-Inoue K Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548 [TBL] [Abstract][Full Text] [Related]
3. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood. Suzuki-Inoue K; Osada M; Ozaki Y J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039 [TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973 [TBL] [Abstract][Full Text] [Related]
5. CLEC-2 Prevents Accumulation and Retention of Inflammatory Macrophages During Murine Peritonitis. Bourne JH; Beristain-Covarrubias N; Zuidscherwoude M; Campos J; Di Y; Garlick E; Colicchia M; Terry LV; Thomas SG; Brill A; Bayry J; Watson SP; Rayes J Front Immunol; 2021; 12():693974. PubMed ID: 34163489 [TBL] [Abstract][Full Text] [Related]
7. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Suzuki-Inoue K Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911 [TBL] [Abstract][Full Text] [Related]
8. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis. Payne H; Ponomaryov T; Watson SP; Brill A Blood; 2017 Apr; 129(14):2013-2020. PubMed ID: 28104688 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532 [TBL] [Abstract][Full Text] [Related]
10. Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse. Lax S; Rayes J; Wichaiyo S; Haining EJ; Lowe K; Grygielska B; Laloo R; Flodby P; Borok Z; Crandall ED; Thickett DR; Watson SP Am J Physiol Lung Cell Mol Physiol; 2017 Dec; 313(6):L1016-L1029. PubMed ID: 28839100 [TBL] [Abstract][Full Text] [Related]
12. Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells. Pollitt AY; Poulter NS; Gitz E; Navarro-Nuñez L; Wang YJ; Hughes CE; Thomas SG; Nieswandt B; Douglas MR; Owen DM; Jackson DG; Dustin ML; Watson SP J Biol Chem; 2014 Dec; 289(52):35695-710. PubMed ID: 25368330 [TBL] [Abstract][Full Text] [Related]
13. Tat-NTS peptide protects neurons against cerebral ischemia-reperfusion injury via ANXA1 SUMOylation in microglia. Zhou H; Yan L; Huang H; Li X; Xia Q; Zheng L; Shao B; Gao Q; Sun N; Shi J Theranostics; 2023; 13(15):5561-5583. PubMed ID: 37908731 [No Abstract] [Full Text] [Related]
14. The Role of CLEC-2 and Its Ligands in Thromboinflammation. Meng D; Luo M; Liu B Front Immunol; 2021; 12():688643. PubMed ID: 34177942 [TBL] [Abstract][Full Text] [Related]
16. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice. Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907 [TBL] [Abstract][Full Text] [Related]
17. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis. Sheng M; Sun R; Fu J; Lu G BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690 [TBL] [Abstract][Full Text] [Related]
18. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling. Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214 [TBL] [Abstract][Full Text] [Related]
19. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis. Rayes J; Lax S; Wichaiyo S; Watson SK; Di Y; Lombard S; Grygielska B; Smith SW; Skordilis K; Watson SP Nat Commun; 2017 Dec; 8(1):2239. PubMed ID: 29269852 [TBL] [Abstract][Full Text] [Related]
20. The platelet-activating receptor C-type lectin receptor-2 plays an essential role in liver regeneration after partial hepatectomy in mice. Kono H; Fujii H; Suzuki-Inoue K; Inoue O; Furuya S; Hirayama K; Akazawa Y; Nakata Y; Sun C; Tsukiji N; Shirai T; Ozaki Y J Thromb Haemost; 2017 May; 15(5):998-1008. PubMed ID: 28294559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]